M. Torabizadeh, V. Dana, S. A. Aghapour, K. Zibara, Z. Zayeri, Elham Rajaei
{"title":"SARS-CoV-2基因与结构研究进展:病毒进入的热细胞靶点","authors":"M. Torabizadeh, V. Dana, S. A. Aghapour, K. Zibara, Z. Zayeri, Elham Rajaei","doi":"10.22037/AMLS.V7.34216","DOIUrl":null,"url":null,"abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses several molecules such as angiotensin-converting enzyme 2 (ACE2), cluster of differentiation 26 (CD26), Ezrin, and Neuropilin-1 (NRP-1) for viral entry. In this review, the entire structural and genomic combination and the mechanism of virus entry, are discussed. This study might be useful for further drug design studies. SARS-CoV-2 neutralization allows the immune system to fight the virus before its entry. COVID-19 enters the host bloodstream by infecting endothelial cells via a cluster of differentiation 147 (CD147). SARS-CoV-2 not only uses ACE2 for its entry but also affects ACE-2 and its enzymatic activity on Ang II and bradykinin, it also imbalances the RAAS and bradykinin system and elevates the inflammation. High levels of bradykinin, cause nonproductive cough as the result of fluid extravasation and leukocyte recruitment to the lung. Accordingly, we suggest replicase transcriptase complex (RTC) and specific non-structural proteins (Nsps) such as Nsp7,8, Nsp10, Nsp12, and Nsp16 are perfect targets of study because RTC and Nsps are the golden elements in the maintenance of COVID-19 appearance and masking. Base on this evidence COVID-19 uses various receptors for its entry and it might block these receptors' activity to evade the immune system and spread to other cells. \n*Corresponding Authors: Elham Rajaei, Email: elhamrj@gmail.com; ORCID: https://orcid.org/0000-0002-8231-0138 \nPlease cite this article as: Torabizadeh M, Ghobadi Dana V, Aghapour SA, Zibara K, Deris Zayeri Z, Rajaei E. A Review of SARS-CoV-2 Genetic and Structure: Hot Cellular Targets for Virus Entry. Arch Med Lab Sci. 2021;7:1-9 (e15). https://doi.org/10.22037/amls.v7.34216","PeriodicalId":18401,"journal":{"name":"Medical laboratory sciences","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A Review of SARS-CoV-2 Genetic and Structure: Hot Cellular Targets for Virus Entry:\",\"authors\":\"M. Torabizadeh, V. Dana, S. A. Aghapour, K. Zibara, Z. Zayeri, Elham Rajaei\",\"doi\":\"10.22037/AMLS.V7.34216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses several molecules such as angiotensin-converting enzyme 2 (ACE2), cluster of differentiation 26 (CD26), Ezrin, and Neuropilin-1 (NRP-1) for viral entry. In this review, the entire structural and genomic combination and the mechanism of virus entry, are discussed. This study might be useful for further drug design studies. SARS-CoV-2 neutralization allows the immune system to fight the virus before its entry. COVID-19 enters the host bloodstream by infecting endothelial cells via a cluster of differentiation 147 (CD147). SARS-CoV-2 not only uses ACE2 for its entry but also affects ACE-2 and its enzymatic activity on Ang II and bradykinin, it also imbalances the RAAS and bradykinin system and elevates the inflammation. High levels of bradykinin, cause nonproductive cough as the result of fluid extravasation and leukocyte recruitment to the lung. Accordingly, we suggest replicase transcriptase complex (RTC) and specific non-structural proteins (Nsps) such as Nsp7,8, Nsp10, Nsp12, and Nsp16 are perfect targets of study because RTC and Nsps are the golden elements in the maintenance of COVID-19 appearance and masking. Base on this evidence COVID-19 uses various receptors for its entry and it might block these receptors' activity to evade the immune system and spread to other cells. \\n*Corresponding Authors: Elham Rajaei, Email: elhamrj@gmail.com; ORCID: https://orcid.org/0000-0002-8231-0138 \\nPlease cite this article as: Torabizadeh M, Ghobadi Dana V, Aghapour SA, Zibara K, Deris Zayeri Z, Rajaei E. A Review of SARS-CoV-2 Genetic and Structure: Hot Cellular Targets for Virus Entry. Arch Med Lab Sci. 2021;7:1-9 (e15). https://doi.org/10.22037/amls.v7.34216\",\"PeriodicalId\":18401,\"journal\":{\"name\":\"Medical laboratory sciences\",\"volume\":\"28 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical laboratory sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22037/AMLS.V7.34216\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical laboratory sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/AMLS.V7.34216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)利用血管紧张素转换酶2 (ACE2)、分化簇26 (CD26)、Ezrin和神经匹林-1 (NRP-1)等分子进入病毒。本文综述了病毒的整体结构和基因组组合以及病毒进入的机制。本研究可能为进一步的药物设计研究提供参考。SARS-CoV-2的中和使免疫系统能够在病毒进入之前与之对抗。COVID-19通过分化簇147 (CD147)感染内皮细胞进入宿主血液。SARS-CoV-2不仅利用ACE2进入,还影响ACE2及其对Ang II和缓激肽的酶活性,使RAAS和缓激肽系统失衡,加重炎症反应。高水平的缓激肽,由于液体外溢和白细胞聚集到肺部而引起非生产性咳嗽。因此,我们认为复制酶转录酶复合体(RTC)和特异性非结构蛋白(Nsps)如Nsp7、8、Nsp10、Nsp12和Nsp16是理想的研究目标,因为RTC和Nsps是维持COVID-19外观和掩蔽的黄金元素。基于这一证据,COVID-19使用各种受体进入,它可能会阻止这些受体的活性,以逃避免疫系统并扩散到其他细胞。*通讯作者:Elham Rajaei, Email: elhamrj@gmail.com;ORCID: https://orcid.org/0000-0002-8231-0138本文全文如下:Torabizadeh M, Ghobadi Dana V, Aghapour SA, Zibara K, Deris Zayeri Z, Rajaei E. SARS-CoV-2基因和结构综述:病毒进入的热细胞靶点。中华医学杂志,2021;7:1-9 (e15)。https://doi.org/10.22037/amls.v7.34216
A Review of SARS-CoV-2 Genetic and Structure: Hot Cellular Targets for Virus Entry:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses several molecules such as angiotensin-converting enzyme 2 (ACE2), cluster of differentiation 26 (CD26), Ezrin, and Neuropilin-1 (NRP-1) for viral entry. In this review, the entire structural and genomic combination and the mechanism of virus entry, are discussed. This study might be useful for further drug design studies. SARS-CoV-2 neutralization allows the immune system to fight the virus before its entry. COVID-19 enters the host bloodstream by infecting endothelial cells via a cluster of differentiation 147 (CD147). SARS-CoV-2 not only uses ACE2 for its entry but also affects ACE-2 and its enzymatic activity on Ang II and bradykinin, it also imbalances the RAAS and bradykinin system and elevates the inflammation. High levels of bradykinin, cause nonproductive cough as the result of fluid extravasation and leukocyte recruitment to the lung. Accordingly, we suggest replicase transcriptase complex (RTC) and specific non-structural proteins (Nsps) such as Nsp7,8, Nsp10, Nsp12, and Nsp16 are perfect targets of study because RTC and Nsps are the golden elements in the maintenance of COVID-19 appearance and masking. Base on this evidence COVID-19 uses various receptors for its entry and it might block these receptors' activity to evade the immune system and spread to other cells.
*Corresponding Authors: Elham Rajaei, Email: elhamrj@gmail.com; ORCID: https://orcid.org/0000-0002-8231-0138
Please cite this article as: Torabizadeh M, Ghobadi Dana V, Aghapour SA, Zibara K, Deris Zayeri Z, Rajaei E. A Review of SARS-CoV-2 Genetic and Structure: Hot Cellular Targets for Virus Entry. Arch Med Lab Sci. 2021;7:1-9 (e15). https://doi.org/10.22037/amls.v7.34216